These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7036061

  • 21. Studies on the biosynthesis of ovarian steroids.
    Sommerville IF, Collins WP.
    Guys Hosp Rep; 1969; 118(3):329-45. PubMed ID: 5356638
    [No Abstract] [Full Text] [Related]

  • 22. Mucinous adenofibroma of the ovary: case report of the endocrinologic findings.
    Tohya T, Mizutani H, Katabuchi H, Miyazaki K, Okamura H.
    Gynecol Oncol; 1994 Aug; 54(2):218-21. PubMed ID: 8063250
    [Abstract] [Full Text] [Related]

  • 23. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J, Shen H, Li J, Huang Z, Zhang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [Abstract] [Full Text] [Related]

  • 24. [Histochemical and ultra-structural studies on the Stein-Leventhal syndrome].
    Tóth F, Horn B, Csömör S.
    Z Geburtshilfe Gynakol; 1970 Aug; 173(1):103-16. PubMed ID: 4098563
    [No Abstract] [Full Text] [Related]

  • 25. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH, Qiao J, Li MZ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 20; 87(11):721-4. PubMed ID: 17565837
    [Abstract] [Full Text] [Related]

  • 26. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ.
    Fertil Steril; 2007 Apr 20; 87(4):870-5. PubMed ID: 17224152
    [Abstract] [Full Text] [Related]

  • 27. Steroidogenic cellular sites in the cat ovary: a histochemical study.
    Saidapur SK.
    Gen Comp Endocrinol; 1978 Aug 20; 35(4):475-80. PubMed ID: 31316
    [No Abstract] [Full Text] [Related]

  • 28. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.
    La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V.
    Fertil Steril; 2004 Oct 20; 82(4):970-2. PubMed ID: 15482785
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Immunocytochemical studies of the ovaries in androgenized women (polycystic ovaries, hyperthecosis)].
    Pickartz H, Moltz L, Altenähr E.
    Acta Histochem Suppl; 1982 Oct 20; 25():101-5. PubMed ID: 6806855
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Endocrinomorphologic correlation of the ovary in menopause].
    González Guerra OV, García Flores RF.
    Ginecol Obstet Mex; 1984 Sep 20; 52(329):227-30. PubMed ID: 6439609
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.